Dr. Reddy's Laboratories Ltd.

  • Home
  • Dr. Reddy's Laboratories Ltd.
Website

Dr. Reddy's Laboratories Ltd. We are a global pharmaceutical company committed to providing affordable & innovative medicines. Dr. Reddy’s Laboratories Ltd.

(BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first
Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Dr. Reddy’s does not collect nor does it require you to share any personal data or personal information, towards your access to or participation in the Facebook event organised by it. You are advised to not disclose any personally identifiable or confidential or non-public information on social media; you are personally responsible for any data that you may decide to share or post on any social media including on this page and Dr. Reddy’s owes no duty or obligation or liability to you or to any other person for the same. All participants on this Facebook event are required to behave with courtesy to others and to not post any offensive/objectionable messages or to intrude into any other person’s rights of privacy.

The U.S. FDA approval of our Rituximab biosimilar marks another important milestone for our growing biologics portfolio....
12/08/2026

The U.S. FDA approval of our Rituximab biosimilar marks another important milestone for our growing biologics portfolio. It is a step forward in our capability to develop and manufacture complex biologics for global markets.

Recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) is a rare and aggressive head and neck cancer that is often di...
03/08/2026

Recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) is a rare and aggressive head and neck cancer that is often diagnosed at an advanced stage. Yet despite advances in cancer treatment over the past decade, innovation for (RM-NPC) has remained limited, highlighting an unmet need for new therapies. The approval of this new immunotherapy marks an important step towards addressing this treatment gap, bringing renewed hope to patients and families affected by the disease in South Africa.

More about the launch in the press release linked in the first comment.

Cancer care has evolved significantly over the past decade, with Immuno-Oncology opening new possibilities for patients ...
03/08/2026

Cancer care has evolved significantly over the past decade, with Immuno-Oncology opening new possibilities for patients across multiple tumour types.

At ABHINANDAN, our Co-Chairman & Managing Director, G.V. Prasad, joined leaders from Biologics and the India Business, along with colleagues from Clinical Development, Medical Affairs and Oncology Marketing, in discussions with principal investigators and advisory board members associated with Nivolumab. The conversations focused on the evolving role of immuno-oncology, the need to expand access to advanced therapies, and the importance of scientific rigor and investigator-industry collaboration in bringing innovation closer to patients.

With the first-to-market launch of Sugammadex Injection, a generic equivalent of Bridion®, in the U.S., we continue expa...
29/07/2026

With the first-to-market launch of Sugammadex Injection, a generic equivalent of Bridion®, in the U.S., we continue expanding our hospital portfolio, reinforcing our commitment to improving patient access to affordable, high-quality medicines.

Read the press release to learn more.

Nearly 300 million people worldwide are living with hepatitis, yet many remain unaware of it until complications arise. ...
28/07/2026

Nearly 300 million people worldwide are living with hepatitis, yet many remain unaware of it until complications arise.

This World Hepatitis Day, we're continuing the conversation around hepatitis, exploring how it spreads, the impact it can have on liver health, and the ways that can help prevent it.


Today we announced our Q1 FY'27 financial results. For more details read the full press release on our website. C...
22/07/2026

Today we announced our Q1 FY'27 financial results. For more details read the full press release on our website.


Click here for full press release:https://www.drreddys.com/cms/sites/default/files/2026-07/FINAL_Earnings_Release_Q1FY27_220726.pdf

14/07/2026

As an organization, the cornerstone of our work is closely aligned with our founder’s values, creating access, enabling livelihoods, and opening up opportunities for people. Our CSR team takes this forward, through initiatives and activities in the areas of education, skilling and livelihoods, healthcare and environmental sustainability.

With this in mind, we started Spirit of Giving, an initiative that gives employees the opportunity to experience this work firsthand alongside our CSR teams, with many returning with a deeper, more personal connection, as seen in Sunil Chebrolu's reflection on how the experience strengthened his sense of purpose and motivation to continue volunteering in alignment with the organization’s values.

Watch our youtube channel for more : https://www.youtube.com/watch?v=n4PejlT2Fzg

Ahead of National Doctors’ Day, we asked our colleagues to share stories of moments when a doctor made them feel seen, h...
01/07/2026

Ahead of National Doctors’ Day, we asked our colleagues to share stories of moments when a doctor made them feel seen, heard, and cared for. We received several heartfelt stories of doctors who took the time to listen, explained things with patience, and helped ease the weight of a difficult situation for patients and their caregivers.
Here are some of those stories in their own words as a tribute to the many ways doctors show up for us, every single day.

29/06/2026

We asked the men in our office simple questions about their health. What came back was honesty we often don’t hear.
Men brush it off. Push through. By the end of the day, they’ve convinced themselves and everyone around them that they’re fine.
But this Men’s Health Awareness Month, we’re choosing to listen more closely, speak more openly, and make space for real conversations.

Launching our 3rd whitepaper, ‘Translational Research Ecosystem: Learnings from the World & Building for India,' from ou...
24/06/2026

Launching our 3rd whitepaper, ‘Translational Research Ecosystem: Learnings from the World & Building for India,' from our joint roundtable with Dr. Reddy’s Institute of Life Sciences (DRILS), moderated by Citeline.

Held in March on the eve of the Dr. Anji Reddy Memorial Lecture, this year’s discussion builds on last year’s focus on innovation, shifting attention to how science can move more effectively into real‑world use.
India has the science and the talent. The challenge lies in building systems that connect discovery to impact across funding, regulation, collaboration, and commercialization.

This carousel brings together perspectives from across the ecosystem on what’s working, what isn’t, and what it will take to move forward.

Address

Dr. Reddy's Laboratories Limited (Corporate Office), Door No 8-2-337, Road No 3, Banjara Hills

500034

Website

Alerts

Be the first to know and let us send you an email when Dr. Reddy's Laboratories Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Want your business to be the top-listed health & beauty business?

Share